Report Categories
View AllRecent Articles
View All
KBDC Kayne posts 52 percent Q4 2025 EPS surprise against forecasts stock slips 11 percent in todays session
REGCO Regency posts 905 percent Q1 2026 EPS beat as stock edges slightly lower in daily trading
OEC Orion SA posts Q1 2026 loss against profit estimates shares dip 132 today
Morgan Stanley MS Ups American Assets Trust AAT 12Month Price Target Following Valuation Framework Refresh
External Links
ANRO Alto Neuro Q4 2025 EPS trails estimates by 71 percent sending shares down 069 percent today
What Wall Street expects from Relmada Therapeutics RLMD this quarter Relmada Therapeutics posts 103 negative EPS miss
Applied Materials Inc AMAT Assessing Regulatory Headwinds Amid US Chip Export Control Legislative Progress
What failed trades Xilio Therapeutics XLO Slight Gain 20260427
What Invesco VVR disclosed about crisis preparedness
What Afya AFYA disclosed about cash conversion Q4 2025 Better Than Expected
What VivoSim Labs VIVS capital allocation tells us Q3 2025 Better Than Expected